Low-Dose Venetoclax with Azacitidine Shows Rapid Remissions in Unfit Elderly AML
A single-center retrospective study of 32 elderly patients reports high remission rates and manageable toxicity with a response-adapted reduced-dose azacitidine-venetoclax ...
